Today: 1 May 2026
UMC stock price: United Microelectronics heads into Monday after AI capex talk sparks chip rebound

UMC stock price: United Microelectronics heads into Monday after AI capex talk sparks chip rebound

TAIPEI, Feb 8, 2026, 10:00 (GMT+8) — The market has closed.

  • UMC’s U.S. shares closed Friday at $10.06, rising roughly 0.9%.
  • Chip stocks rallied, lifted by Amazon and Alphabet signaling bigger bets on AI infrastructure.
  • Attention now turns to U.S. events set for Feb. 12-13, with UMC also due to release its next monthly sales figures on March 5.

United Microelectronics Corp’s U.S. shares wrapped up Friday trading at $10.06, climbing late along with other chip names. The stock opens this week just under $10, still sitting roughly 21% off its 52-week peak of $12.68.

Markets have been closed for the weekend, but traders are already zeroing in on the next set of cues: U.S. economic numbers, results from chip-equipment makers, and clues about whether the AI-driven spending boom is still going. Capital expenditures—capex—basically refer to outlays for gear and added production muscle, and they tend to drive chip demand in a hurry.

After Amazon announced it expects capital expenditures to surge more than 50% this year—echoing Alphabet’s signal earlier in the week—tech shares caught a bid. Nvidia jumped 7.8%. The Philadelphia semiconductor index tacked on 5.7%. Ross Mayfield, investment strategy analyst at Baird, flagged “real demand for AI products” as a key driver following a bruising selloff. reuters.com

After three days in the red, stocks bounced back as investors reconsidered how AI might hit tech margins—and whether valuations had run too hot. “A healthy selloff,” said Robert Pavlik, senior portfolio manager at Dakota Wealth, who thinks the market’s showing “cooler heads” when it comes to AI’s timeline for shaking things up. Pavlik flagged projections that Amazon, Microsoft, Alphabet, and Meta together could pour around $600 billion into AI by 2026. reuters.com

Other stocks tied to foundry operations posted even bigger gains. Taiwan Semiconductor Manufacturing’s U.S. shares closed the day up roughly 5.5%. GlobalFoundries wasn’t far behind, climbing almost 4.7%.

UMC shares in Taipei finished Friday at NT$61.90, ticking up 0.65%.

Industry sentiment remains upbeat. On Friday, the Semiconductor Industry Association projected global chip sales would reach $1 trillion this year, coming off $791.7 billion in 2025—a 25.6% jump. SIA chief John Neuffer told Reuters, “my orders are completely full,” calling the sector’s trajectory a “strong glide path” through next year. reuters.com

UMC, a contract chipmaker, does wafer fabrication—basically building chips to spec for its clients. Investors sometimes look at it as a read on the broader electronics cycle, even if everyone’s focused on the latest AI chip buzz.

Still, this move looks like little more than a bounce. Should cloud budgets turn out choppier than investors expect, or if non-AI demand remains sluggish, smaller foundries could see their pricing power evaporate in a hurry.

Next on the docket for the U.S.: The Employment Situation and the January CPI inflation report both hit on Feb. 13, 8:30 a.m. Eastern. That pairing has the potential to move bond yields and shake up tech valuations.

Chip-equipment names could be in focus as earnings roll in, with Applied Materials on deck for a key report Feb. 12.

UMC is set to report February monthly sales on March 5, the company said.

Stock Market Today

  • Seaport Therapeutics Upsizes IPO to $255M, CEO Highlights New Biotech Pathway
    May 1, 2026, 2:02 PM EDT. Seaport Therapeutics raised $254.9 million in an upsized Nasdaq IPO, exceeding initial $180 million estimates. CEO Daphne Zohar highlighted a shift from traditional M&A (mergers and acquisitions) to public offerings, reflecting confidence in developing and marketing their depression drug pipeline independently. The company may raise an additional $38.2 million through underwriters' option. Zohar pointed to industry changes where biotech firms are now focusing on advancing medicines directly to patients, citing success stories like Karuna Therapeutics and Intra-Cellular Therapies. Seaport's board recently welcomed Sharon Mates, who led Intra-Cellular to a $1.5 billion drug launch before its J&J acquisition. This IPO signals renewals in the biotech public market despite recent Big Pharma dealmaking.

Latest article

Dow Jones Today: Why the Blue-Chip Rally Stalled as Apple, S&P 500 and Nasdaq Pushed Higher

Dow Jones Today: Why the Blue-Chip Rally Stalled as Apple, S&P 500 and Nasdaq Pushed Higher

1 May 2026
The Dow Jones Industrial Average fell 78.72 points to 49,573.42 by midday Friday, reversing an early rally as tariff concerns weighed on gains from Apple and other strong earnings reports. President Donald Trump announced a 25% tariff on EU-made cars and trucks starting next week. Apple reported quarterly revenue of $111.2 billion, up 17% year over year. Oil prices dropped after Iran sent a new negotiation proposal.
US Stock Market Today: Why the S&P 500 and Nasdaq Are Hitting Fresh Highs

US Stock Market Today: Why the S&P 500 and Nasdaq Are Hitting Fresh Highs

1 May 2026
The S&P 500 rose 0.48% and the Nasdaq 0.96% to record highs Friday, while the Dow slipped 0.11%. Apple shares climbed after reporting its strongest quarterly sales growth in over four years. Atlassian and other software stocks rallied on strong cloud demand. Exxon and Chevron beat profit estimates but cited pressure from Middle East conflict and volatile oil prices.
Recursion Pharmaceuticals Stock: Founder Chris Gibson to Leave Board as RXRX Nears Q1 Earnings

Recursion Pharmaceuticals Stock: Founder Chris Gibson to Leave Board as RXRX Nears Q1 Earnings

1 May 2026
Recursion Pharmaceuticals said founder and board chair Chris Gibson will not seek re-election at the June 17 annual meeting, months after stepping down as CEO. The company reports first-quarter results May 6, with investors watching for updates on cash, clinical progress, and its AI drug platform. Recursion last reported $753.9 million in cash and narrowed its quarterly net loss. Gibson will remain chair until his term ends.
Renesas stock price jumps again as $3 billion SiTime deal keeps traders hooked on 6723
Previous Story

Renesas stock price jumps again as $3 billion SiTime deal keeps traders hooked on 6723

UOL stock draws heavy short-selling as Singapore market shuts for weekend
Next Story

UOL stock draws heavy short-selling as Singapore market shuts for weekend

Go toTop